TEVA-OXYCODAN 325 MG
ACETYLSALICYLIC ACID : 325 MG OXYCODONE HYDROCHLORIDE : 5 MG · DIN 00608157 · TEVA CANADA LIMITED
Health Canada status: MARKETED
What is TEVA-OXYCODAN?
TEVA-OXYCODAN 325 MG contains ACETYLSALICYLIC ACID : 325 MG OXYCODONE HYDROCHLORIDE : 5 MG. It is listed in the Health Canada Drug Product Database under DIN 00608157, held by TEVA CANADA LIMITED, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 21-Dec-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is TEVA-OXYCODAN used for?
Relief of mild to moderately severe pain, including conditions accompanied by fever and/or inflammation in adults. Not for as-needed (prn) use.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 00608157 |
|---|---|
| Brand name | TEVA-OXYCODAN |
| Generic / active ingredient | ACETYLSALICYLIC ACID : 325 MG OXYCODONE HYDROCHLORIDE : 5 MG |
| Manufacturer | TEVA CANADA LIMITED |
| Strength | 325 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | NARCOTICS (CDSA I) |
| ATC code | N02AJ18 OXYCODONE AND ACETYLSALICYLIC ACID |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 21-Dec-2017 |
How is it administered?
Adults: 1 tablet every 6 hours as needed. Max 7 days for acute pain. Swallow whole; do not crush or chew. Titrate to lowest effective dose.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store securely to avoid theft or misuse. (Specific temperature range not provided in text snippet, but standard pharmaceutical storage applies).
How is it supplied?
Bottles of 100 and 500 tablets.
Contraindications
Hypersensitivity to opioids or ASA; GI obstruction; respiratory depression; severe asthma; CNS depression; head injury; MAO inhibitors; nasal polyps/asthma with ASA; peptic ulcers; bleeding disorders.
Warnings and precautions
Serious risk of fatal overdose if crushed/chewed. Risk of addiction, abuse, and misuse. Respiratory depression. Reye’s syndrome risk in young adults. Severe hypotension.
What can be used instead?
Other Canadian products sharing ATC code N02AJ18 OXYCODONE AND ACETYLSALICYLIC ACID. 1 of 5 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ENDODAN | 5 MG | TABLET | BRISTOL-MYERS SQUIBB CANADA | CANCELLED POST MARKET | DIN 01916483 |
| PERCODAN | 325 MG | TABLET | BRISTOL-MYERS SQUIBB CANADA | CANCELLED POST MARKET | DIN 01916572 |
| PERCODAN-DEMI | 325 MG | TABLET | BRISTOL-MYERS SQUIBB CANADA | CANCELLED POST MARKET | DIN 01916556 |
| RIVACODAN | 325 MG | TABLET | LABORATOIRE RIVA INC. | CANCELLED PRE MARKET | DIN 02242395 |
Who else supplies OXYCODONE AND ACETYLSALICYLIC ACID worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. OXYCODONE AND ACETYLSALICYLIC ACID appears in 240 registered pack listings across 9 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.